We are excited and grateful to announce being awarded "Most Promising Company" following the pitch competition at the 2022 Texas Life Science Forum! #lifescience#precisionmedicine#oncology#biotech
Excited and grateful that we received $500K from an angel investor, enabling us to move forward with our CLIA LDT certification and prototype testing for CAL, a first-in-class precision cancer diagnostic instrument.